Trial Outcomes & Findings for Views on COVID-19 and Vaccination (NCT NCT04706403)
NCT ID: NCT04706403
Last Updated: 2022-05-24
Results Overview
All participants were asked about their intent to be vaccinated against COVID-19 prior to exposure to one of the five physician messages (Response options: Yes, No, Not sure). After participants were randomly assigned to receive one of the five physician messages, reduction in COVID-19 vaccine hesitancy was assessed with the question: "Would you get vaccinated at this visit". Response options included yes, no, not sure. For participants whose initial vaccination intent was "not sure", a response of "yes" on re-assessment was defined as less hesitant. Response of "not sure" or "yes" were defined as less hesitant for participants whose initial vaccination intent was "no".
COMPLETED
NA
756 participants
Through survey completion, an average of 12 minutes
2022-05-24
Participant Flow
Participants were recruited on Prolific.co from 01/12/21-02/01/21. Eligible panel members were \>= 18, English speaking, and U.S residents. Panel members were restricted to include White, Black, or Hispanic; Blacks and Hispanics were oversampled. Participants who responded "no" or "not sure" to "If you could get vaccinated for COVID-19 today, would you?" were classified as vaccine hesitant and randomized to receive 1 of 5 physician messages, after which their intent was reassessed.
Participant milestones
| Measure |
Message 1
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
|
Message 2
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
|
Message 3
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
|
Message 4
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
|
Message 5
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
172
|
121
|
165
|
146
|
152
|
|
Overall Study
COMPLETED
|
172
|
121
|
164
|
145
|
150
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
1
|
1
|
2
|
Reasons for withdrawal
| Measure |
Message 1
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
|
Message 2
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
|
Message 3
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
|
Message 4
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
|
Message 5
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
|
|---|---|---|---|---|---|
|
Overall Study
Participants did not provide respond to the question re-assessing vaccination intent
|
0
|
0
|
1
|
1
|
2
|
Baseline Characteristics
Views on COVID-19 and Vaccination
Baseline characteristics by cohort
| Measure |
Message 1
n=172 Participants
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
|
Message 2
n=121 Participants
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
|
Message 3
n=164 Participants
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
|
Message 4
n=145 Participants
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgement of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
|
Message 5
n=150 Participants
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
|
Total
n=752 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Customized
Age · Less than 24 years
|
43 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
38 Participants
n=4 Participants
|
41 Participants
n=21 Participants
|
190 Participants
n=10 Participants
|
|
Age, Customized
Age · 25 - 34 years
|
40 Participants
n=5 Participants
|
32 Participants
n=7 Participants
|
42 Participants
n=5 Participants
|
28 Participants
n=4 Participants
|
42 Participants
n=21 Participants
|
184 Participants
n=10 Participants
|
|
Age, Customized
Age · 35 - 44 years
|
50 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
50 Participants
n=4 Participants
|
33 Participants
n=21 Participants
|
191 Participants
n=10 Participants
|
|
Age, Customized
Age · 45 - 54 years
|
22 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
17 Participants
n=4 Participants
|
20 Participants
n=21 Participants
|
107 Participants
n=10 Participants
|
|
Age, Customized
Age · 55 - 64 years
|
13 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
11 Participants
n=21 Participants
|
58 Participants
n=10 Participants
|
|
Age, Customized
Age · 65 years or older
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
15 Participants
n=10 Participants
|
|
Age, Customized
Age · Missing
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
7 Participants
n=10 Participants
|
|
Sex/Gender, Customized
Gender · Male
|
62 Participants
n=5 Participants
|
41 Participants
n=7 Participants
|
71 Participants
n=5 Participants
|
52 Participants
n=4 Participants
|
65 Participants
n=21 Participants
|
291 Participants
n=10 Participants
|
|
Sex/Gender, Customized
Gender · Female
|
108 Participants
n=5 Participants
|
78 Participants
n=7 Participants
|
88 Participants
n=5 Participants
|
93 Participants
n=4 Participants
|
82 Participants
n=21 Participants
|
449 Participants
n=10 Participants
|
|
Sex/Gender, Customized
Gender · Other
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
6 Participants
n=10 Participants
|
|
Sex/Gender, Customized
Gender · Prefer not to say
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=10 Participants
|
|
Sex/Gender, Customized
Gender · Missing
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
3 Participants
n=21 Participants
|
5 Participants
n=10 Participants
|
|
Race/Ethnicity, Customized
Hispanic/Latino
|
35 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
41 Participants
n=5 Participants
|
33 Participants
n=4 Participants
|
37 Participants
n=21 Participants
|
177 Participants
n=10 Participants
|
|
Race/Ethnicity, Customized
Black/African American
|
79 Participants
n=5 Participants
|
52 Participants
n=7 Participants
|
66 Participants
n=5 Participants
|
64 Participants
n=4 Participants
|
65 Participants
n=21 Participants
|
326 Participants
n=10 Participants
|
|
Race/Ethnicity, Customized
White
|
58 Participants
n=5 Participants
|
37 Participants
n=7 Participants
|
57 Participants
n=5 Participants
|
48 Participants
n=4 Participants
|
48 Participants
n=21 Participants
|
248 Participants
n=10 Participants
|
|
Race/Ethnicity, Customized
Missing
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=10 Participants
|
|
Region of Enrollment
United States
|
172 participants
n=5 Participants
|
121 participants
n=7 Participants
|
164 participants
n=5 Participants
|
145 participants
n=4 Participants
|
150 participants
n=21 Participants
|
752 participants
n=10 Participants
|
|
Initial Vaccination Intent
Initially "No"
|
103 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
83 Participants
n=5 Participants
|
78 Participants
n=4 Participants
|
81 Participants
n=21 Participants
|
411 Participants
n=10 Participants
|
|
Initial Vaccination Intent
Initially "Not Sure"
|
69 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
81 Participants
n=5 Participants
|
67 Participants
n=4 Participants
|
69 Participants
n=21 Participants
|
341 Participants
n=10 Participants
|
|
Education
High School or Less
|
44 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
38 Participants
n=4 Participants
|
49 Participants
n=21 Participants
|
224 Participants
n=10 Participants
|
|
Education
Some college
|
86 Participants
n=5 Participants
|
56 Participants
n=7 Participants
|
85 Participants
n=5 Participants
|
70 Participants
n=4 Participants
|
68 Participants
n=21 Participants
|
365 Participants
n=10 Participants
|
|
Education
4-year college or more
|
42 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
36 Participants
n=4 Participants
|
32 Participants
n=21 Participants
|
160 Participants
n=10 Participants
|
|
Education
Missing
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
3 Participants
n=10 Participants
|
|
Employment
Employed
|
88 Participants
n=5 Participants
|
64 Participants
n=7 Participants
|
83 Participants
n=5 Participants
|
83 Participants
n=4 Participants
|
76 Participants
n=21 Participants
|
394 Participants
n=10 Participants
|
|
Employment
Unemployed
|
30 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
20 Participants
n=4 Participants
|
30 Participants
n=21 Participants
|
129 Participants
n=10 Participants
|
|
Employment
Student
|
25 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
19 Participants
n=4 Participants
|
18 Participants
n=21 Participants
|
92 Participants
n=10 Participants
|
|
Employment
Homemaker
|
16 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
14 Participants
n=4 Participants
|
13 Participants
n=21 Participants
|
64 Participants
n=10 Participants
|
|
Employment
Disabled
|
6 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
5 Participants
n=21 Participants
|
28 Participants
n=10 Participants
|
|
Employment
Retired
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
21 Participants
n=10 Participants
|
|
Employment
Other
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
22 Participants
n=10 Participants
|
|
Employment
Missing
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
2 Participants
n=10 Participants
|
|
Household Income
Less than $30,000
|
47 Participants
n=5 Participants
|
43 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
40 Participants
n=4 Participants
|
57 Participants
n=21 Participants
|
242 Participants
n=10 Participants
|
|
Household Income
$30,000 - $60,000
|
53 Participants
n=5 Participants
|
41 Participants
n=7 Participants
|
57 Participants
n=5 Participants
|
51 Participants
n=4 Participants
|
53 Participants
n=21 Participants
|
255 Participants
n=10 Participants
|
|
Household Income
$60,000 - $100,000
|
44 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
35 Participants
n=5 Participants
|
26 Participants
n=4 Participants
|
27 Participants
n=21 Participants
|
159 Participants
n=10 Participants
|
|
Household Income
More than $100,000
|
21 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
19 Participants
n=4 Participants
|
9 Participants
n=21 Participants
|
67 Participants
n=10 Participants
|
|
Household Income
Prefer not to answer
|
6 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
3 Participants
n=21 Participants
|
25 Participants
n=10 Participants
|
|
Household Income
Missing
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
4 Participants
n=10 Participants
|
|
Geographic region
South
|
90 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
80 Participants
n=5 Participants
|
75 Participants
n=4 Participants
|
80 Participants
n=21 Participants
|
391 Participants
n=10 Participants
|
|
Geographic region
Midwest
|
28 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
34 Participants
n=5 Participants
|
31 Participants
n=4 Participants
|
21 Participants
n=21 Participants
|
131 Participants
n=10 Participants
|
|
Geographic region
West
|
28 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
15 Participants
n=4 Participants
|
33 Participants
n=21 Participants
|
120 Participants
n=10 Participants
|
|
Geographic region
Northeast
|
26 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
24 Participants
n=4 Participants
|
16 Participants
n=21 Participants
|
110 Participants
n=10 Participants
|
|
History of flu shot
Ever, in the last 5 years
|
73 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
70 Participants
n=5 Participants
|
78 Participants
n=4 Participants
|
71 Participants
n=21 Participants
|
332 Participants
n=10 Participants
|
|
History of flu shot
Not sure or no
|
99 Participants
n=5 Participants
|
81 Participants
n=7 Participants
|
93 Participants
n=5 Participants
|
67 Participants
n=4 Participants
|
79 Participants
n=21 Participants
|
419 Participants
n=10 Participants
|
|
History of flu shot
Missing
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=10 Participants
|
|
Self-rated overall health
Excellent
|
22 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
13 Participants
n=21 Participants
|
69 Participants
n=10 Participants
|
|
Self-rated overall health
Very good
|
44 Participants
n=5 Participants
|
34 Participants
n=7 Participants
|
48 Participants
n=5 Participants
|
40 Participants
n=4 Participants
|
39 Participants
n=21 Participants
|
205 Participants
n=10 Participants
|
|
Self-rated overall health
Good
|
69 Participants
n=5 Participants
|
51 Participants
n=7 Participants
|
66 Participants
n=5 Participants
|
58 Participants
n=4 Participants
|
65 Participants
n=21 Participants
|
309 Participants
n=10 Participants
|
|
Self-rated overall health
Fair
|
27 Participants
n=5 Participants
|
19 Participants
n=7 Participants
|
34 Participants
n=5 Participants
|
33 Participants
n=4 Participants
|
24 Participants
n=21 Participants
|
137 Participants
n=10 Participants
|
|
Self-rated overall health
Poor
|
9 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
8 Participants
n=21 Participants
|
30 Participants
n=10 Participants
|
|
Self-rated overall health
Missing
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
2 Participants
n=10 Participants
|
|
Self-rated overall mental health
Excellent
|
22 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
12 Participants
n=4 Participants
|
18 Participants
n=21 Participants
|
91 Participants
n=10 Participants
|
|
Self-rated overall mental health
Very good
|
43 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
33 Participants
n=4 Participants
|
30 Participants
n=21 Participants
|
174 Participants
n=10 Participants
|
|
Self-rated overall mental health
Good
|
42 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
48 Participants
n=5 Participants
|
47 Participants
n=4 Participants
|
50 Participants
n=21 Participants
|
225 Participants
n=10 Participants
|
|
Self-rated overall mental health
Fair
|
51 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
35 Participants
n=4 Participants
|
40 Participants
n=21 Participants
|
185 Participants
n=10 Participants
|
|
Self-rated overall mental health
Poor
|
14 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
17 Participants
n=4 Participants
|
12 Participants
n=21 Participants
|
76 Participants
n=10 Participants
|
|
Self-rated overall mental health
Missing
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=10 Participants
|
PRIMARY outcome
Timeframe: Through survey completion, an average of 12 minutesPopulation: Four participants were excluded from the analyses because they did not respond to the question re-assessing vaccination intent following exposure to a physician recommendation.
All participants were asked about their intent to be vaccinated against COVID-19 prior to exposure to one of the five physician messages (Response options: Yes, No, Not sure). After participants were randomly assigned to receive one of the five physician messages, reduction in COVID-19 vaccine hesitancy was assessed with the question: "Would you get vaccinated at this visit". Response options included yes, no, not sure. For participants whose initial vaccination intent was "not sure", a response of "yes" on re-assessment was defined as less hesitant. Response of "not sure" or "yes" were defined as less hesitant for participants whose initial vaccination intent was "no".
Outcome measures
| Measure |
Message 1
n=172 Participants
Participants were randomized to receive version #1 of 5 different versions of a message from a physician regarding the COVID-19 vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 1, this statement was followed by a participatory-style recommendation ("What do you think?")
|
Message 2
n=121 Participants
Participants were randomized to receive version #2 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 2, this statement was followed by a comparison of the COVID-19 vaccine to the flu shot and an explicit recommendation ("I recommend that you get it").
|
Message 3
n=164 Participants
Participants were randomized to receive version #3 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 3, this statement was followed by a statement that millions of people have already received the COVID-19 vaccine and an explicit recommendation ("I recommend that you get it").
|
Message 4
n=145 Participants
Participants were randomized to receive version #4 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 4, this statement was followed by an acknowledgment of concerns and reassurance that the physician personally reviewed the safety data and an explicit recommendation ("I recommend that you get it").
|
Message 5
n=150 Participants
Participants were randomized to receive version #5 of 5 different versions of a message from a physician regarding vaccination. All messages included a statement that the vaccine is very safe and very effective. In Message 5, this statement was followed by an emphasis on protecting others an explicit recommendation ("I recommend that you get it").
|
|---|---|---|---|---|---|
|
Number of Participants Who Became Less Hesitant About the COVID-19 Vaccine After Receiving a Physician Message
|
23 Participants
|
26 Participants
|
43 Participants
|
35 Participants
|
40 Participants
|
Adverse Events
Message 1
Message 2
Message 3
Message 4
Message 5
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place